申请人:Rigel Pharmaceuticals, Inc.
公开号:US20140378429A1
公开(公告)日:2014-12-25
The disclosure relates particularly to certain carboxamide, sulfonamide and amine compounds and pharmaceutical compositions thereof, and to methods of treating and ameliorating disorders and conditions related to the adiponectin pathway, sphingolipid metabolism, oxidative stress, mitochondrial dysfunction, free radical damage and metabolic inefficiency, among others. In certain embodiments, the compounds have the structures (I-1), (2-I) and (3-I) (The chemical formulas should be inserted here) in which the variables are as described herein.
本公开涉及特定的羧酰胺、磺酰胺和胺化合物及其制药组合物,以及治疗和改善与脂联素途径、鞘脂代谢、氧化应激、线粒体功能障碍、自由基损伤和代谢效率等相关的疾病和病症的方法。在某些实施例中,化合物具有结构(I-1)、(2-I)和(3-I)(化学式应在此处插入),其中变量如本文所述。